Have You or a Loved One Suffered from Fournier’s Gangrene After Taking Farxiga?
If you or someone you know has suffered from Fournier’s Gangrene while taking Type 2 diabetes medications like Farxiga, you may be entitled to financial compensation.
Don’t wait to reach out – your health may be on the line.
Life-Threatening Infection Linked to Farxiga
Adults with Type 2 diabetes rely on prescription drugs like Farxiga (or its extended-release counterpart, Xigduo), to help lower their blood sugar, but some are reporting that they’ve suffered serious injuries after taking the medications. Our attorneys at Cory Watson are investigating claims that these drugs could cause serious infections, and even death, in some patients.
The FDA recently warned that SGLT2 medications such as Farxiga are associated with an increased risk of Fournier’s Gangrene, a serious flesh-eating bacterial infection of the genital area.
Other Type 2 diabetes drugs that may be linked to gangrene include:
Compensation from a Farxiga Lawsuit
The unexpected tragedy of genital gangrene can be life-changing. We understand that you may be facing costly procedures or complete lifestyle changes.
An experienced Farxiga lawsuit attorney will advocate for you to receive financial compensation to help pay for:
- Past and present medical expenses
- Lost income due to missed work
- Home renovations such as wheelchair access
- In-home treatment or physical therapy
- Emotional trauma and suffering
Call today and find out what you are owed for your losses. You don’t pay unless we win your case, but the time to claim compensation is limited.
CONTACT OUR EXPERIENCED FARXIGA ATTORNEYS
Cory Watson Attorneys has recovered more than $3 Billion for clients across the United States, and we’re ready to fight for you.
Our attorneys are investigating Farxiga lawsuits across the country on behalf of victims who experienced harmful side effects while taking SGLT2 inhibitor diabetes medications.
Call (877) 562-0000 or complete a free initial consultation form on this page to get help now.
Invokana® and Invokamet® are registered trademarks of Janssen Pharmaceuticals, Inc., and are used here only to identify the products in question. Farxiga® and Xigduo XR® are registered trademarks of Astrazeneca, plc, and are used here only to identify the products in question. Jardiance® and Glyxambi® are registered trademarks of Boehringer Ingelheim Pharmaceuticals, Inc., and are used here only to identify the products in question.
This law firm is not associated with, sponsored by, or affiliated with AstraZeneca plc; Boehringer Ingelheim Pharmaceuticals, Inc.; Janssen Pharmaceticals, Inc.; or the U.S. Food and Drug Administration.